Further to intimation dated December 03, 2025 and pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations, 2015), Biocon has informed that the Board of Directors of Biocon at its meeting held today, i.e. on December 06, 2025 has transacted the following business: Increase in Authorised Share Capital and consequential amendment to the Memorandum of Association of the Company; Acquisition of equity shares of Biocon Biologics Limited and issuance of equity shares on a preferential basis; Fund Raising; Convening of Extra-Ordinary General Meeting (EGM); and Issuance of Commercial Papers. The above-mentioned information will also be available on the website of the Company at www.biocon.com. Further, the Board Meeting commenced at 8:55 AM and concluded at 9:20 AM.
The above information is a part of company’s filings submitted to BSE.
